Tag: bioabsorbable stents market share analysis

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Bioabsorbable Stents Market Growth Potential: How Will Market Size Shift Through 2030?

The bioabsorbable stents market size has shown rapid growth in recent years. It is anticipated to expand from $0.41 billion in 2025 to $0.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The market’s historical growth can be attributed to several factors, including the increasing prevalence of cardiovascular diseases, the widespread adoption of interventional cardiology procedures, the early utilization of biodegradable polymers in medical implants, the rise in coronary stent procedures, and advancements in vascular intervention techniques.

The bioabsorbable stents market is projected to experience substantial expansion in the coming years. This market is forecast to reach $0.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This projected growth is driven by factors such as the increasing need for temporary vascular support, a heightened emphasis on long-term patient results, the expanding scope of treatments for peripheral artery disease, increased investments in biodegradable implant research, and a rise in regulatory approvals for new stent materials. Key trends anticipated during this period involve the accelerating development of advanced bioabsorbable materials, the growing uptake of polymer-based bioabsorbable stents, a concentrated effort to minimize long-term complications, the broadening of clinical trials for peripheral applications, and a stronger focus on ensuring biocompatibility and safety.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=24766769&type=smp&name=Bioabsorbable%20Stents%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Bioabsorbable Stents Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The expansion of the bioabsorbable stents market is projected to be propelled by the growing incidence of heart failure. This condition arises when the heart muscle’s capacity to effectively pump blood diminishes, leading to an accumulation of surplus fluid in the body. Bioabsorbable stents offer a solution for managing heart failure, as they can improve cardiac function and alleviate associated symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based information provider on stroke, heart disease, surgeries, and treatments, currently identifies 750,000 people with a heart failure diagnosis, alongside an annual addition of 100,000 new instances of this irreversible illness. Furthermore, forecasts suggest that by 2030, annual healthcare spending related to heart failure in Canada is expected to reach $2.8 billion. Consequently, the escalating occurrence of heart failure is set to significantly foster the expansion of the bioabsorbable stents market in the future.

Bioabsorbable Stents Market Segment Performance And Emerging Opportunities

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

Bioabsorbable Stents Market Innovation Trends Shaping Future Development

Companies operating within the bioabsorbable stents market are increasingly concentrating on developing innovative technologies, including the Latest Generation of Bioresorbable Cardiac Stent, to enhance their profitability. The latest generation of bioresorbable cardiac stents represents advanced medical devices specifically engineered for the treatment of coronary artery disease, constructed from biodegradable materials that gradually dissipate after effectively keeping the artery open. For instance, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, successfully obtained market authorization from China’s National Medical Products Administration (NMPA) for the world’s first next-generation fully bioresorbable cardiac stent. Developed by MicroPort Scientific Corporation, the Firesorb stent is designed to completely resorb within three years, leading to a substantial reduction in long-term complications such as thrombosis. Clinical trials conducted with 1,468 patients have revealed impressive results, including a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of just 4.3%. Prominent medical experts have lauded its innovative thin strut design and its superior endothelial coverage when compared to earlier stent generations.

Bioabsorbable Stents Market Leading Players And Competitive Positioning

Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.

View The Full Bioabsorbable Stents Market Report:

https://thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Bioabsorbable Stents Market Regional Distribution: Which Areas Power Market Growth?

North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Bioabsorbable Stents Market During 2026–2030?

The bioabsorbable stents market has shown significant growth in recent years. This market is anticipated to expand from $0.41 billion in 2025 to $0.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. The market’s historical development can be ascribed to factors including the escalating prevalence of cardiovascular diseases, the increasing uptake of interventional cardiology procedures, the early utilization of biodegradable polymers in medical implants, the proliferation of coronary stent procedures, and advancements in vascular intervention techniques.

The bioabsorbable stents market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $0.65 billion, growing at a compound annual growth rate (CAGR) of 9.5%. This anticipated growth within the forecast period stems from factors such as a heightened demand for temporary vascular support solutions, an increased emphasis on ensuring positive long-term patient outcomes, the broadening of treatments for peripheral artery disease, increased investments in research pertaining to biodegradable implants, and the rising number of regulatory approvals for new stent materials. Key trends projected during this period encompass the accelerated development of advanced bioabsorbable materials, a growing acceptance of polymer-based bioabsorbable stents, an intensified focus on minimizing long-term complications, the expansion of clinical trials for applications in peripheral areas, and a stronger emphasis on ensuring both biocompatibility and safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Key Growth Drivers Are Influencing The Bioabsorbable Stents Market?

The escalating incidence of heart failure is projected to stimulate the expansion of the bioabsorbable stents market. This condition, marked by the heart muscle’s diminished capacity to effectively pump blood, leads to fluid buildup in the body. Bioabsorbable stents offer a solution for managing heart failure, improving cardiac function and alleviating symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based organization providing information on stroke, heart disease, surgeries, and treatments, currently identifies 750,000 individuals with heart failure, with an additional 100,000 new diagnoses of this irreversible condition each year. By 2030, healthcare costs associated with heart failure in Canada are expected to hit $2.8 billion annually. Consequently, the rising prevalence of heart failure will drive the future growth of the bioabsorbable stents market. A significant driver for the bioabsorbable stents market is the increasing geriatric population. This demographic typically includes individuals aged 65 and above, classified as older adults. The rise in the geriatric population is fueled by longer life expectancies, largely due to advancements in healthcare that allow people to live longer. Bioabsorbable stents prove advantageous for older individuals because they gradually dissolve after restoring blood flow, thereby minimizing long-term complications and removing the necessity for permanent implants in elderly patients, who are more prone to delayed adverse effects. For instance, the World Health Organization, a US-based specialized health agency, reported in October 2025 that the global population aged 80 and above is predicted to triple by 2050, reaching approximately 426 million people. Thus, the expanding geriatric population is propelling the growth of the bioabsorbable stents market.

What Are The Major Segment Categories Within The Bioabsorbable Stents Market?

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What Trends Are Affecting The Growth Of The Bioabsorbable Stents Market?

Companies operating in the bioabsorbable stents market are increasingly concentrating on developing new technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to enhance their market profitability. These modern bioresorbable cardiac stents are sophisticated medical instruments used to treat coronary artery disease, fabricated from biodegradable substances that naturally degrade once they have served their purpose of maintaining arterial patency. For example, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, secured market approval from China’s National Medical Products Administration (NMPA) for what is considered the world’s inaugural next-generation fully bioresorbable cardiac stent. This device, named Firesorb, was developed by MicroPort Scientific Corporation and is engineered to completely dissolve within three years, thereby considerably lessening prolonged complications like thrombosis. Clinical investigations conducted with 1,468 patients have yielded notable outcomes, demonstrating a minimal thrombosis rate of 0.32% and a 4-year target lesion failure rate of only 4.3%. Prominent medical professionals have commended its pioneering thin strut architecture and enhanced endothelial coverage when contrasted with earlier stent versions.

Which Companies Are Influencing The Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.

Access The Complete Bioabsorbable Stents Market Report:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Region Is The Primary Market For The Bioabsorbable Stents Market?

North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Bioabsorbable Stents Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2026, By The Business Research Company

Portable Food Safety Detectors Market Report 2026

https://www.thebusinessresearchcompany.com/report/portable-food-safety-detectors-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Laboratory Accessories Market Report 2026

https://www.thebusinessresearchcompany.com/report/laboratory-accessories-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Bioabsorbable Stents Market Grow Between 2026 And 2030?

The bioabsorbable stents market has seen rapid expansion in recent years. It is anticipated to increase from $0.41 billion in 2025 to $0.45 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. This historical growth can be attributed to several factors including the increasing prevalence of cardiovascular diseases, the adoption of interventional cardiology procedures, the early use of biodegradable polymers in medical implants, the growth of coronary stent procedures, and advancements in vascular intervention techniques.

The bioabsorbable stents market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $0.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include the escalating demand for temporary vascular support, a heightened emphasis on long-term patient results, the broader application of peripheral artery disease treatments, increased investment in biodegradable implant research, and a rise in regulatory approvals for new stent materials. Key trends observed within this period encompass the development of advanced bioabsorbable materials, the growing uptake of polymer-based bioabsorbable stents, a concentrated effort on minimizing long-term complications, the expansion of clinical trials for peripheral uses, and a greater focus on biocompatibility and safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

Which Strong Drivers Are Impacting The Bioabsorbable Stents Market Growth?

The escalating prevalence of heart failure is anticipated to fuel the expansion of the bioabsorbable stents market. Heart failure is medically defined by the heart muscle’s impaired ability to effectively circulate blood, leading to an accumulation of surplus fluid throughout the body. Bioabsorbable stents can be utilized in treating heart failure to boost cardiac efficiency and lessen its manifestations. For example, the Heart and Stroke Foundation of Canada, a Canada-based informational body on stroke, heart disease, surgeries, and treatments, has reported 750,000 individuals are currently diagnosed with heart failure, with an additional 100,000 new cases of this incurable ailment emerging annually. Forecasts suggest that by 2030, healthcare spending attributed to heart failure in Canada is expected to reach $2.8 billion per year. Thus, the increasing incidence of heart failure will drive the growth of the bioabsorbable stents market moving forward.

Which Segments Define The Bioabsorbable Stents Market Segment Structure?

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

Which Trends Are Contributing To Changes In The Bioabsorbable Stents Market?

Companies operating within the bioabsorbable stents market are prioritizing the creation of novel technologies, including the Latest Generation of Bioresorbable Cardiac Stent, to enhance their market profitability. The latest generation of bioresorbable cardiac stents represents advanced medical implants designed for treating coronary artery disease, manufactured from biodegradable substances that naturally dissolve after fulfilling their role of keeping the artery open. As an illustration, in July 2024, MicroPort Scientific Corporation, a China-based manufacturer of medical devices, successfully obtained market clearance for the world’s inaugural next-generation fully bioresorbable cardiac stent from China’s National Medical Products Administration (NMPA). Firesorb, developed by MicroPort Scientific Corporation, is engineered to entirely resorb within three years, thereby considerably reducing long-term complications such as thrombosis. Clinical trials, which included 1,468 patients, have revealed impressive results, featuring a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of just 4.3%. Leading medical experts have commended its innovative thin strut design and superior endothelial coverage when compared to previous generations of stents.

Who Are The Established Players Within The Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.

Get The Full Bioabsorbable Stents Market Report:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Region Is The Top Contributor To The Bioabsorbable Stents Market By Share?

North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bioabsorbable Stents Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2026, By The Business Research Company

Portable Food Safety Detectors Market Report 2026

https://www.thebusinessresearchcompany.com/report/portable-food-safety-detectors-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Laboratory Accessories Market Report 2026

https://www.thebusinessresearchcompany.com/report/laboratory-accessories-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Bioabsorbable Stents Market By 2030 Starting From Its 2026 Size?

The bioabsorbable stents market has seen substantial expansion in recent years. It is anticipated to grow from $0.41 billion in 2025 to $0.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The growth observed in prior periods stemmed from the increasing prevalence of cardiovascular diseases, the widespread adoption of interventional cardiology procedures, the initial use of biodegradable polymers in medical implants, the rise in coronary stent procedures, and advancements in vascular intervention techniques.

The bioabsorbable stents market size is anticipated to demonstrate robust growth in the upcoming years. It is projected to expand to $0.65 billion in 2030, recording a compound annual growth rate (CAGR) of 9.5%. This growth in the forecast period can be attributed to various factors, including the increasing demand for temporary vascular support solutions, a rising focus on long-term patient outcomes, the expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, and increasing regulatory approvals for novel stent materials. Key trends expected during the forecast period encompass the increasing development of next-generation bioabsorbable materials, a rising adoption of polymer-based bioabsorbable stents, a growing focus on reduced long-term complications, the expansion of clinical trials for peripheral applications, and an enhanced emphasis on biocompatibility and safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Bioabsorbable Stents Market?

The rising incidence of heart failure is anticipated to propel the expansion of the bioabsorbable stents market. This condition is defined by the heart muscle’s impaired capacity to effectively pump blood, leading to an excess accumulation of fluid within the body. Bioabsorbable stents offer a therapeutic option for managing heart failure, working to improve cardiac function and alleviate its manifestations. For example, the Heart and Stroke Foundation of Canada, a Canada-based organization providing data on stroke, heart disease, operations, and treatments, currently identifies 750,000 individuals with heart failure, with an additional 100,000 new diagnoses of this incurable condition occurring each year. Furthermore, by 2030, medical spending associated with heart failure in Canada is forecast to reach $2.8 billion annually. Consequently, the increasing prevalence of heart failure is poised to drive the growth of the bioabsorbable stents market in the forthcoming period.

Which Segment Categories Define The Bioabsorbable Stents Market?

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What Major Market Trends Are Driving Changes In The Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market are concentrating on innovating new technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to boost their profitability in the market. This latest generation of bioresorbable cardiac stents refers to advanced medical devices intended for treating coronary artery disease, which are manufactured from biodegradable materials that gradually dissipate after fulfilling their role of maintaining the artery open. For instance, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, recently secured market approval from China’s National Medical Products Administration (NMPA) for the world’s first next-generation fully bioresorbable cardiac stent. Developed by MicroPort Scientific Corporation, Firesorb is engineered to completely dissolve within three years, substantially reducing long-term complications like thrombosis. Clinical trials involving 1,468 patients have revealed impressive outcomes, including a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of just 4.3%. Leading medical experts have lauded its innovative thin strut design and superior endothelial coverage compared to previous stent generations.

Who Are The Top Companies Competing In The Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.

Read the full bioabsorbable stents market report here:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Regions Are Projected To Dominate The Bioabsorbable Stents Market In The Coming Years?

North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bioabsorbable Stents Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2026, By The Business Research Company

Portable Food Safety Detectors Market Report 2026

https://www.thebusinessresearchcompany.com/report/portable-food-safety-detectors-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Laboratory Accessories Market Report 2026

https://www.thebusinessresearchcompany.com/report/laboratory-accessories-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the metaverse retail market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Bioabsorbable Stents Market’s size between 2026 and 2030?

The bioabsorbable stents market size has experienced rapid growth in recent years. This market is projected to expand from $0.41 billion in 2025 to $0.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. Historically, this expansion can be linked to factors such as the rising incidence of cardiovascular diseases, the increasing uptake of interventional cardiology procedures, the initial application of biodegradable polymers in medical implants, the surge in coronary stent procedures, and continuous advancements in vascular intervention techniques.

The bioabsorbable stents market is projected to experience significant growth in the coming years, with its size expected to reach $0.65 billion by 2030, at a compound annual growth rate (CAGR) of 9.5%. This growth in the forecast period can be attributed to several factors, including an increasing demand for temporary vascular support solutions, a rising focus on long-term patient outcomes, the expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, and increasing regulatory approvals for novel stent materials. Major trends anticipated during this period include the accelerated development of next-generation bioabsorbable materials, a rising adoption of polymer-based bioabsorbable stents, an intensified focus on reducing long-term complications, the expansion of clinical trials for peripheral applications, and an enhanced emphasis on biocompatibility and safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

Which Drivers Are Shaping Strategic Decisions In The Bioabsorbable Stents Market?

The expanding incidence of heart failure is anticipated to fuel the expansion of the bioabsorbable stents market. This condition, marked by the heart muscle’s diminished capacity to effectively circulate blood and subsequent fluid buildup in the body, can be managed with bioabsorbable stents. These devices improve cardiac function and alleviate associated symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based provider of information on stroke, heart disease, surgeries, and treatments, currently identifies 750,000 individuals living with heart failure, with 100,000 new cases of this irreversible ailment reported each year. By 2030, it is projected that healthcare costs associated with heart failure in Canada will amount to $2.8 billion per annum. Consequently, the rising prevalence of heart failure is expected to drive the future growth of the bioabsorbable stents market. The increasing number of older adults is predicted to stimulate the expansion of the bioabsorbable stents market in the future. This demographic, typically comprising individuals aged 65 and above, is expanding as a result of extended life expectancy, propelled by advancements in healthcare that allow people to live longer. Bioabsorbable stents offer advantages to this older demographic because they progressively dissipate after re-establishing blood flow, thereby minimizing long-term complications and removing the requirement for permanent implants in elderly patients who are more prone to delayed adverse events. For instance, the World Health Organization, a US-based specialized health agency, reported in October 2025 that the global population of those aged 80 and older is forecast to triple by 2050, reaching approximately 426 million. Consequently, the expanding geriatric population is a key factor driving the growth of the bioabsorbable stents market.

What Segment Classifications Make Up The Bioabsorbable Stents Market?

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What Long-Term Trends Are Expected To Shape The Future Of The Bioabsorbable Stents Market?

Companies engaged in the bioabsorbable stents market are concentrating on developing novel technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to enhance their market profitability. This advanced class of bioresorbable cardiac stents refers to sophisticated medical devices intended for the treatment of coronary artery disease, fabricated from biodegradable materials that naturally dissolve over time after successfully maintaining arterial openness. For instance, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, recently obtained market approval for the world’s first next-generation fully bioresorbable cardiac stent from China’s National Medical Products Administration (NMPA). Firesorb, developed by MicroPort Scientific Corporation, is engineered to entirely dissolve within three years, which considerably lessens long-term complications such as thrombosis. Clinical trials involving 1,468 patients revealed impressive results, including a minimal thrombosis rate of 0.32% and a 4-year target lesion failure rate of merely 4.3%. Leading medical experts have lauded its innovative thin strut design and enhanced endothelial coverage compared to prior stent generations.

Which Major Firms Are Strengthening Their Position In The Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Bioabsorbable Stents Market?

North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Bioabsorbable Stents Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2026, By The Business Research Company

Portable Food Safety Detectors Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/portable-food-safety-detectors-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Laboratory Accessories Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/laboratory-accessories-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the bioabsorbable stents market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Bioabsorbable Stents Market In The Period 2029-2034?

The bioabsorbable stents market has shown robust growth over recent years. It is anticipated to expand from $0.37 billion in 2024 to $0.41 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.2%. This historical market expansion is primarily due to factors such as the rising prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, increasing awareness of bioabsorbable stents, rising disposable incomes, and industry investments.

The market for bioabsorbable stents is projected to experience robust expansion over the upcoming years. This market is anticipated to reach a valuation of $0.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.9%. This projected growth is driven by factors such as expanded clinical indications, customization and personalization, global expansion, and the availability of patient-friendly options. Key trends foreseen in this period encompass advancements in bioabsorbable materials, clinical advancements, a focus on clinical data and research, the development of hybrid stent designs, longer absorption periods, and strategic collaborations and partnerships.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Strategic Drivers Are Accelerating The Bioabsorbable Stents Market Expansion?

The rising incidence of heart failure is projected to fuel the expansion of the bioabsorbable stents market. This condition occurs when the heart muscle’s capacity to pump blood effectively diminishes, leading to fluid retention in the body. Bioabsorbable stents can be utilized in managing heart failure, improving heart function and alleviating symptoms. As an illustration, the Heart and Stroke Foundation of Canada, which provides information on stroke, heart disease, surgeries, and treatments, reported in February 2022 that 750,000 people were diagnosed with heart failure, with an additional 100,000 new cases of this incurable condition occurring each year. Furthermore, by 2030, annual healthcare costs linked to heart failure in Canada are expected to hit $2.8 billion. Consequently, the escalating prevalence of heart failure is set to propel the expansion of the bioabsorbable stents market in the future.

What Is The Detailed Segment Distribution Of The Bioabsorbable Stents Market?

The bioabsorbable stentsmarket covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

Which Market Trends Are Expected To Define The Future Of The Bioabsorbable Stents Market?

Leading companies within the bioabsorbable stents market are concentrating on developing advanced technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to enhance their market profitability. This newest generation of bioresorbable cardiac stents represents sophisticated medical devices intended for treating coronary artery disease, crafted from biodegradable substances that naturally degrade once they have served their purpose of maintaining arterial patency. An example of this is MicroPort Scientific Corporation, a medical device producer based in China, which secured market approval for the planet’s inaugural next-generation fully bioresorbable cardiac stent from China’s National Medical Products Administration (NMPA) in July 2024. Firesorb, created by MicroPort Scientific Corporation, is engineered to fully dissolve within three years, thereby substantially mitigating long-term complications including thrombosis. Clinical studies involving 1,468 patients have demonstrated remarkable outcomes, reporting a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of only 4.3%. Prominent medical professionals have commended its pioneering thin strut design and superior endothelial coverage when contrasted with earlier stent generations.

Who Are The Major Stakeholders Operating In The Bioabsorbable Stents Market?

Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Bioabsorbable Stents Market?

North America was the largest region in the bioabsorbable stents market in 2024. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2025, By The Business Research Company

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Bifurcation Lesions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

Peripheral Vascular Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Bioabsorbable Stents Market Size During 2025–2029?

The overall valuation of the bioabsorbable stents sector has experienced significant expansion lately; projecting forward, this market is anticipated to see its value climb from $0.37 billion in 2024 to reach $0.41 billion by 2025, reflecting a consistent compound annual growth rate of 9.2% during this forecast interval. This upward trajectory seen in the past can be linked to several key factors, including an increasing incidence of heart-related illnesses, a heightened need for surgical techniques that involve less intrusion, greater general knowledge regarding absorbable stent technology, growing levels of personal wealth, and substantial capital infusion from within the industry.

Projections indicate a robust expansion for the market encompassing bioabsorbable stents over the coming years, with its valuation anticipated to reach $0.59 billion by 2029, propelled by a compound annual growth rate (CAGR) of 9.9%; this upward trajectory during the forecast timeframe is fundamentally driven by broader clinical applications becoming available, the tailoring of products to individual needs, worldwide market penetration efforts, and the inherent advantages these devices offer to patients.Key developments shaping the industry throughout this forecast interval encompass progress in the development of bioabsorbable substances, breakthroughs in medical procedures, ongoing studies and published clinical evidence, the emergence of stent structures combining different technologies, the engineering of devices with extended dissolution timelines, and strategic alliances and cooperative ventures forged between entities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Are The Drivers Pushing New Developments In The Bioabsorbable Stents Market?

Elevated occurrences of cardiac insufficiency are anticipated to fuel the expansion within the market for bioabsorbable stents. This condition, known as heart failure, involves a diminished capacity of the heart muscle to effectively circulate blood, which subsequently leads to an undesirable buildup of excessive bodily fluids. The utilization of bioabsorbable stents offers a therapeutic avenue for addressing heart failure, aiming to improve cardiac function and alleviate associated clinical manifestations. As an illustration, data released in February 2022 by the Heart and Stroke Foundation of Canada, an established Canadian authority on stroke, cardiovascular ailments, necessary procedures, and therapies, indicated that 750,000 Canadians are presently living with a heart failure diagnosis, alongside an additional 100,000 new instances diagnosed each year for this chronic, untreatable ailment. Furthermore, forecasts suggest that by the year 2030, the yearly financial commitment within Canada for heart failure healthcare could climb to $2.8 billion, thereby cementing the rising incidence of heart failure as a key impetus for the future growth of the bioabsorbable stents market.

Which Key Segments Fueling The Bioabsorbable Stents Market?

The bioabsorbable stentsmarket covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What Long-Term Trends Will Shape The Future Growth Of The Bioabsorbable Stents Industry?

Key players within the bioabsorbable stents sector are directing their efforts toward developing novel technologies, exemplified by the Next Generation of Bioresorbable Cardiac Stent, as a means to enhance their market earnings. This newer category of bioresorbable cardiac stents comprises sophisticated medical implants intended for managing coronary artery disease, constructed from materials capable of breaking down naturally once the vessel has been successfully scaffolded open. To illustrate this advancement, in July 2024, MicroPort Scientific Corporation, a manufacturer of medical equipment situated in China, secured official authorization from China’s National Medical Products Administration (NMPA) for what is globally recognized as the inaugural next-generation, completely absorbable cardiac stent. This device, conceptualized and engineered by MicroPort Scientific Corporation and known as Firesorb, is engineered to fully disintegrate within a three-year span, therefore substantially mitigating protracted risks like blood clotting. Data sourced from clinical evaluations involving 1,468 participants have demonstrated highly favorable outcomes, notably achieving a thrombosis incidence of merely 0.32% and a 4-year rate of target lesion failure standing at only 4.3%. Esteemed authorities in medicine have lauded its ground breaking thin-strut architecture and its excellence in covering the vessel lining when juxtaposed with earlier stent models.

Which Major Industry Participants Are Leading The Bioabsorbable Stents Market Growth?

Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

What Are The Key Regional Factors Influencing The Bioabsorbable Stents Market Growth?

North America was the largest region in the bioabsorbable stents market in 2024. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The Bioabsorbable Stents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2025, By The Business Research Company

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Bifurcation Lesions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

Peripheral Vascular Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Bioabsorbable Stents Market Growth Performance Trended Historically, And What Lies Ahead?

The market for bioabsorbable stents has seen a robust growth rate in the past few years. The market is set to expand from a valuation of $0.37 billion in 2024 to $0.41 billion in 2025, marking a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this growth in the prior years include an increase in cases of cardiovascular diseases, a rising preference for minimally invasive procedures, an enhanced consciousness about bioabsorbable stents, an uptick in disposable incomes and considerable investments made in the industry.

Anticipated to witness robust growth in the coming years, the bioabsorbable stents market is projected to expand to $0.59 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 9.9%. It’s expected growth in the forecast period can be ascribed to numerous factors such as broadened clinical indications, customization and personalization, worldwide expansion, and its appeal as a patient-friendly option. Noteworthy trends in the forecast period encompass advancements in bioabsorbable materials, clinical breakthroughs, extensive clinical data and research, more enduring absorption periods, hybrid stent designs, in addition to collaborations and partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBioabsorbable Stents Market?

The bioabsorbable stents market’s growth is anticipated to be fueled by the rising prevalence of heart failure. Heart failure, defined by a decreased capability of the heart muscle to effectively pump blood leading to an excess fluid buildup within the body, can be managed using bioabsorbable stents to improve cardiac performance and alleviate symptoms. For example, the Heart and Stroke Foundation of Canada, a leading informational resource on heart diseases, surgeries, strokes, and treatments, reported that as of February 2022, there are around 750,000 persons diagnosed with heart failure, with an additional 100,000 new cases annually of this incurable ailment. Future estimates suggest that by 2030, the annual healthcare costs related to heart failure in Canada are projected to hit $2.8 billion. As a result, the escalating occurrence of heart failure is likely to spur the expansion of the bioabsorbable stents market.

Which Segments in the Bioabsorbable Stents Offer the Most Growth?

The bioabsorbable stentsmarket covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBioabsorbable Stents Market?# Market?

North America was the largest region in the bioabsorbable stents market in 2024. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Are the Current Market Growth and Trends in the Bioabsorbable Stents Industry?

Key players in the bioabsorbable stents market are driving their growth by introducing innovative developments, such as the latest generation of Bioresorbable Cardiac Stents, to increase their market profitability. The new generation of bioresorbable cardiac stents includes cutting-edge medical apparatus which are used in the treatment of coronary artery disease, manufactured from biodegradable materials that gradually dissolve after fulfilling their purpose of maintaining the artery open. For instance, MicroPort Scientific Corporation, a medical device company based in China, got the approval for the first next-generation fully bioresorbable cardiac stent globally from the National Medical Products Administration (NMPA) in China during July 2024. This stent, Firesorb, also developed by MicroPort Scientific Corporation, is expected to fully dissolve within three years, thereby significantly decreasing long-term issues such as thrombosis. Clinical trials involving 1,468 patients delivered impressive findings, including a thrombosis rate as low as 0.32% and only a 4.3% rate of target lesion failure in four years. The stent’s innovative design featuring thin struts and superior endothelial coverage, as compared to previous stent generations, has received commendations from top medical experts.

View the full report here:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

What Are the Key Elements That Define the Bioabsorbable Stents Market?

Bioabsorbable stents are tubes inserted into blood vessels to unblock passageways and dissolve in the body after a period of time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3269

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the bioabsorbable stents industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Bioabsorbable Stents Market From 2025 To 2029?

In recent years, the market size for bioabsorbable stents has seen robust growth. The market is set to expand from $0.37 billion in 2024 to $0.41 billion in 2025, following a compound annual growth rate (CAGR) of 9.9%. Factors contributing to growth during the historical period include an escalating occurrence of cardiovascular diseases, a surge in demand for procedures that are minimally invasive, enhanced understanding of bioabsorbable stents, growth of disposable incomes, and investments within the industry.

The market for bioabsorbable stents is predicted to experience substantial growth in the coming years, reaching an estimated value of $0.59 billion in 2029 with a compound annual growth rate (CAGR) of 9.8%. This projected growth during the forecast period can be credited to factors like broader clinical applications, customized and individualized approaches, international expansion, and more patient-comfortable options. Leading trends during this period are expected to involve progress in bioabsorbable materials, clinical advancements, extensive clinical data and research, hybrid stent models, extended absorption times, and strategic collaborations and partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Bioabsorbable Stents Market?

The bioabsorbable stents market is anticipated to experience a boost owing to the escalating heart failure rates. Heart failure, symptomatic of the heart muscle’s diminished capacity to pump blood effectively causing fluid to build up in the body, can be managed using bioabsorbable stents. These stents aid in improving cardiac function and alleviating the symptoms of heart failure. As noted by the Heart and Stroke Foundation of Canada, as of February 2022, 750,000 individuals are currently diagnosed with heart failure. This figure is increasing by 100,000 new cases yearly, underscoring the incurable nature of this condition. It is forecasted that by the year 2030, heart failure-related healthcare costs in Canada will skyrocket to an annual figure of $2.8 billion. Thus, the escalating heart failure rates will propel the growth of the bioabsorbable stents market in the future.

Which Key Market Segments Comprise the Bioabsorbable Stents Market and Drive Its Revenue Growth?

The bioabsorbable stents market covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Which Areas Are Leading Regions in the Bioabsorbable Stents Market Expansion Across the Globe?

North America was the largest region in the bioabsorbable stents market in 2023. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Are the Strategic Trends Steering the Bioabsorbable Stents Market Direction?

Prominent enterprises in the bioabsorbable stents market are prioritising the innovation of new technologies such as the newest version of Bioresorbable Cardiac Stent, in order to enhance their market profitability. This contemporary generation of bioresorbable cardiac stents are sophisticated medical devices meant for treating coronary artery disease. They are composed of biodegradable materials that gradually dissolve after they have fulfilled their purpose of keeping the artery unblocked. For instance, in July 2024, MicroPort Scientific Corporation, a medical device manufacturer based in China, obtained market clearance from China’s National Medical Products Administration (NMPA) for the global first next-generation entirely bioresorbable cardiac stent. Firesorb, created by MicroPort Scientific Corporation, is designed to totally dissolve within three years, substantially minimizing long-term issues like thrombosis. Clinical trials with 1,468 participants have demonstrated outstanding outcomes, including a thrombosis rate of merely 0.32% and a target lesion failure rate of a mere 4.3% over four years. Its cutting-edge thin strut design and exceptional endothelial coverage compared to older stent generations have been lauded by top medical experts.

View the full report here:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

How Is the Bioabsorbable Stents Market Conceptually Defined?

Bioabsorbable stents are tubes inserted into blood vessels to unblock passageways and dissolve in the body after a period of time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3269

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model